Ireland
--:--IST
Latest
Clinical Trials in Switzerland / NCT07283055
Enrolling by invitation Not applicable

A Swiss Interprofessional Network for Reviewing Inappropriate Medication in Primary Care

NCT07283055 · tracked via the Priya Life Science Switzerland tracker
Phase
Not applicable
Started
2026-02-02
Last updated
2026-02-13

Condition(s) studied

Medication ReviewPrimary Care

Investigational drug(s) / intervention(s)

Medication review

Medication review: * Step 1 (optional): Patients taking at least 10 chronic medications and experiencing adherence or side effect issues may benefit from a specialised consultation with a pharmacist. * Step 2: The pharmacist identifies any medication-related issues for each patient and discusses them directly with the general practitioner in order to agree on the necessary adjustments. * Step 3: During a medical appointment, the doctor and patient will decide together whether to implement the proposed changes. * Step 4: The pharmacist will follow up after a few days and then again after 3 months.

Study summary

The aim of the SINERGIC pilot study is to assess the feasibility in the Swiss context of implementing interprofessional medication reviews between GP and pharmacists, as part of a shared decision-making process with patients. The acceptability and potential effectiveness of such an intervention will also be assessed.

This assessment will enable the investigators to take into account the determining factors for setting up a large-scale study to support the sustainable financing of this service in the long term.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Age ≥ 65 years old; * Regular use of at least 5 medications (chronic treatments, \> 3 months); * Patients with a minimum of 3 chronic diseases; * Regular follow-up in a GP practice taking part in the project; * Adequate understanding of French. * Written informed consent Exclusion Criteria: * Residence in an institution (residential care facility, nursing home, etc.) ; * Cognitive impairment preventing understanding or obtaining informed consent; * Any other clinical situation deemed incompatible with participation, as decided by the GP in charge.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Institute of Primary Health Care (BIHAM) Bern Switzerland

More University of Bern trials in Switzerland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07283055 on ClinicalTrials.gov ↗ ← All trials in Switzerland